Related Experiment Video
Updated: Jun 26, 2025

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Reduction in presynaptic dopamine transporter may be associated with future problematic delusion
Hiroshi Kataoka1, Kaoru Kinugawa1, Mayu Sugata1
1Department of Neurology, Nara Medical University, Nara, Japan.
Reduced dopamine transporter (DAT) binding in Parkinson's disease (PD) patients may predict future delusions. This finding offers a potential objective risk indicator for psychosis in PD.
Area of Science:
- Neuroscience
- Neurology
- Radiology
Background:
- Psychosis, particularly delusions, significantly diminishes the quality of life for Parkinson's disease (PD) patients and their caregivers.
- Objective indicators for predicting psychosis in PD are limited, and the role of dopamine transporter (DAT) binding remains unclear.
- Long-term prognostic data on DAT binding for predicting delusions in PD are lacking.
Purpose of the Study:
- To investigate whether baseline dopamine transporter (DAT) binding, measured by [123I]FP-CIT SPECT, serves as a prognostic risk factor for the future development of delusions in Parkinson's disease (PD).
- To assess the association between striatal DAT binding and the occurrence of delusions within a 5-year follow-up period.
Main Methods:
- Retrospective chart review of 61 Parkinson's disease (PD) patients without prior psychosis who underwent [123I]FP-CIT SPECT.
- Delusions occurring within 5 years post-SPECT were defined as the study endpoint.
- Specific binding ratio (SBR) values in the striatum were calculated and compared between patients who developed delusions and those who did not, with adjustments for confounding factors.
Main Results:
- Eleven out of 61 PD patients developed delusions within 5 years of [123I]FP-CIT SPECT.
- Significantly lower average, minimum, maximum, right-sided, and left-sided striatal SBRs were observed in patients who developed delusions compared to those who did not (p < 0.004 for all).
- These differences remained significant after controlling for age, gender, disease severity, medication, and other clinical factors.
Conclusions:
- Reduced dopamine transporter (DAT) binding in the striatum is a significant predictor of future delusion development in Parkinson's disease (PD) patients.
- Striatal DAT binding, assessed via [123I]FP-CIT SPECT, can serve as an objective prognostic marker for psychosis in PD.
- Lowering DAT binding may be a valuable indicator for predicting future delusions, irrespective of the timing of the SPECT scan.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Positive Symptoms Schizophrenia: Hallucinations and Delusions
Hallucinations
Hallucinations in...
Drugs Affecting Neurotransmitter Synthesis
Psychosis and Antipsychotic Drugs: Overview
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...

